Patient characteristics
| Subject characteristic (N = 27) . | . |
|---|---|
| Age, yr | Median, 65 (range, 42-81) |
| Sex | |
| Men:women | 21 (75%):6 (25%) |
| Prior therapies | Median, 1 (range, 1-5) |
| >1 prior therapy | 7 |
| Prior autologous stem cell transplant | |
| Yes:no | 12 (44%):15 (56%) |
| Response to last therapy | |
| Responder | 18 (67%) |
| Nonresponder | 6 (22%) |
| Unknown/not evaluable | 3 (11%) |
| Ki67 (n = 13) | |
| Median | 30% (range, 5%-90%) |
| ≥30% | 7/13 (54%) |
| MIPI | |
| Low | 9 (33%) |
| Intermediate | 11 (41%) |
| High | 7 (26%) |
| Subject characteristic (N = 27) . | . |
|---|---|
| Age, yr | Median, 65 (range, 42-81) |
| Sex | |
| Men:women | 21 (75%):6 (25%) |
| Prior therapies | Median, 1 (range, 1-5) |
| >1 prior therapy | 7 |
| Prior autologous stem cell transplant | |
| Yes:no | 12 (44%):15 (56%) |
| Response to last therapy | |
| Responder | 18 (67%) |
| Nonresponder | 6 (22%) |
| Unknown/not evaluable | 3 (11%) |
| Ki67 (n = 13) | |
| Median | 30% (range, 5%-90%) |
| ≥30% | 7/13 (54%) |
| MIPI | |
| Low | 9 (33%) |
| Intermediate | 11 (41%) |
| High | 7 (26%) |
MIPI, Mantle Cell International Prognostic Index.